None, D. V. V., None, D. A. S. G., None, D. N. T. & None, D. N. G. (2026). Spirometry as a tool for assessing asthma control in children on follow up. Journal of Contemporary Clinical Practice, 12(11), 370-374.
MLA
None, Dr Varsha VP, et al. "Spirometry as a tool for assessing asthma control in children on follow up." Journal of Contemporary Clinical Practice 12.11 (2026): 370-374.
Chicago
None, Dr Varsha VP, Dr Anisha S George , Dr Nithindas TY and Dr Neetu Gupta . "Spirometry as a tool for assessing asthma control in children on follow up." Journal of Contemporary Clinical Practice 12, no. 11 (2026): 370-374.
Harvard
None, D. V. V., None, D. A. S. G., None, D. N. T. and None, D. N. G. (2026) 'Spirometry as a tool for assessing asthma control in children on follow up' Journal of Contemporary Clinical Practice 12(11), pp. 370-374.
Vancouver
Dr Varsha VP DVV, Dr Anisha S George DASG, Dr Nithindas TY DNT, Dr Neetu Gupta DNG. Spirometry as a tool for assessing asthma control in children on follow up. Journal of Contemporary Clinical Practice. 2026 Nov;12(11):370-374.
Background: Assessing level of control of asthma continues to be a challenge to pediatricians. Spirometry is the gold standard test recommended by GINA for adult patients in asthma diagnosis as well as follow up. But role of spirometry in follow up of childhood asthma is not well studied. Objectives: To study the changes in different variables in spirometry compared to baseline on follow up in childhood asthma, To study the association between level of control assessed clinically and by spirometry. Participants and methods: Children more than 5 years of age, who were clinically diagnosed as asthma and on regular preventers according to GINA guidelines, were included. All these participants had a spirometry done at the start of prophylaxis. On follow up, level of control was assessed clinically using questionnaire-based Childhood Asthma Control Test(C-ACT) and spirometry was repeated after 6-12 months of regular prophylaxis. Changes in various spirometry parameters were compared to baseline values. Level of asthma control assessed clinically by C-ACT score was compared with that by spirometry. Results: 105 children were eligible for our study out of which 65 children were followed up and analysed. Out of these 65 children, FEV1, FEV1/ FVC and FEV 25-75% improved in 52.3%,53.8% and 56.9% children respectively. In majority of children who showed FEV1 and FEV 25-75% improvement, variability also improved.Level of control assessed clinically and by FEV1 showed moderate correlation (Kappa-0.35). Other spirometric parameters showed no correlation with clinical level of control. Conclusion: In around half of the children, spirometric parameters improved on follow up. In most of the children who showed improvement in FEV1 and FEV 25-75%, variability also reduced on follow up. Moderately significant correlation was found between FEV1 improvement and clinical improvement measured by C ACT score. Other spirometric parameters showed no correlation with clinical level of control
Keywords
Spirometry
Childhood asthma
Asthma follow up
Childhood asthma Control Test
INTRODUCTION
Early diagnosis and good control of asthma is mandatory for improving the course of the disease. However, assessing control of childhood asthma is challenging and subjective. Spirometry has been recommended recently as an essential step for diagnosis of asthma in the children above 5 years.1 Adult physicians use spirometry in diagnosis as well as to know the level of control and to modify the treatment if required. But the role of spirometry on follow up visits in pediatric population is not clear. Non availability of spirometry in most centers and unawareness of pediatricians about the interpretation of spirometry contribute to the lack of pediatric data. Hence, we studied the changes in various variables on spirometry and compared with the baseline spirometry. We also tried to find out the association between level of control assessed clinically and control based on spirometry improvement.
MATERIALS AND METHODS
Our study was done at pediatric respiratory clinic of tertiary care,600 beddedmultispecialty hospital center in southern Kerala.Study was conducted over a duration of 2years (June 2017 to June 2019).Sample size of our study was determined by power analysis. Probability of finding significance where there is none (alpha) was set to 0.05(Z value for 95% confidence being Z=1.96)and probability of finding true significance , power set to 0.80. Taking previous studies as reference, in 45% of children, spirometric assessment was different from clinical assessment.2We included all children more than 5 years attending the Pediatric Respiratory Clinic who were clinically diagnosed as childhood asthma and started on preventer therapy as per GINA guidelines after baseline spirometry. Proper compliance with preventers and technique of using them were ensured before enrolling. Children who were on regular prophylaxis but no baseline spirometry available and non-cooperative children were excluded. Ethical clearance was obtained and informed consent taken from all patients.
The severity of asthma of each child was then classified according to GINA guidelines on the basis of impairment and risk into 4 categories: Intermittent asthma, Mild-persistent, Moderate persistent and severepersistent.1 Spirometry was performed by respiratory technician for all these children after at least 6 months of regular preventers as a part of unit protocol. Testing was performed using PNEUMOTRAC (Manufactured by VITALOGRAPH, Ireland)-standard machine as per American Thoracic Society Standards.3We used thepredicted referencevalues of South Indian population based on age, sex, ethnicity, height and weight as normal. Testing was performed before and after administration of levosalbutamol nebulization (1.25mg). Three reproducible tests were obtained before and 10-15minutes after bronchodilator administration. During spirometry, ATS 2005 guidelines were followed up to select acceptable and reproducible tests.
Tests were interpreted by the asthma specialist. All these patients were followed up by the principal investigator and the clinical profile of these children were documented along with spirometry parameters.Clinical level of asthma control was assessed by questionnaire based Childhood asthma control test. Changes in different variables of spirometry were compared to baseline variables. Clinical level of control was compared with that assessed by follow-up spirometry. All data were entered in MS excel and analyzed using statistical software SPSS 16.0. 95% confidence interval for the outcome and a p-value less than 0.05 was considered statistically significant.Spirometric improvement was defined by an increase in FEV1, FEV1/ FVC ratio and FEV 25-75% as well as reduction in variability of FEV1 and FEV25- 75% on follow up as compared with baseline values. Clinical improvement was categorized as well controlled and not well controlled according to childhood ACT score. Correlation between level of control clinically and by spirometry was statistically analyzed with measure of kappa agreement (0.3-0.6 as moderate correlation and more than 0.6 as strong correlation) and Pearson chi square test for significance.
RESULTS
Out of 105 children who fulfilled the inclusion criteria, 40 were excluded (Lost follow up-35, Non cooperative-5). Thus we analyzed 65 children for study. Demographic profile of enrolled children is presented in Table I.
Based on C- ACT score, 56.9%( 37/65) children were well controlled on follow up, whereas 43%( 28/65) were either poorly controlled or uncontrolled. On analyzing the changes in variable spirometry parameters compared to baseline spirometry, FEV1, FEV 25-75% and FEV1 ratio improved improved in 52.3%, 56.9% and 53.8% of analyzed children respectively. The extent of improvement of each parameter are summarized in Table II
Table I
Frequency Percent
Age in years >8years 51 78.4
<8years 14 21.6
Sex Male 41 63.1
Female 24 36.9
Associated comorbidity No comorbidity 21 32.3
Allergic rhinitis 37 56.9
Food allergy 4 6.2
AR+ Food allergy 3 4.6
Positive family history 39 60
Duration between baseline and follow-up spirometry 6m-1 year 34 52
1-2 year 26 40
>2year 5 8
Table II
Extent of improvement <10% >10% Variability reduced
FEV1 n=34 41.2% (14/34) 58.8(20/34) 31/34 (92%)
FEV1 Ratio n=35 77% (27/35) 22.8% (8/35) NA
FEV 25-75% n=37 29.7% (11/37) 70.2(26/37) 27/37 (72%)
Out of 65 children enrolled, 34 children showed improvement in FEV1.Among these 34 children 92% showed reduction in variability. Also, 37 out of the 65 children showed improvement in FEV25-75%. Among them 72% showed variability improvement.
Level of asthma control was assessed with clinical questionnaire and spirometric variable and both were compared. Comparison of different variables are summated in Table III
Table III
Clinical level of control Accuracy Kappa agreement
Well Controlled Not well controlled
FEV1 Well controlled 25 9
67.7
.350
Not well controlled 12 19
FEV1 ratio Well controlled 22 13
56.9
.297
Not well controlled 15 15
FEV 25-75 Well controlled 25 12
63.1
.046
Not well controlled 12 16
FEV1
Variability Well controlled 28 16
61.5
.191
Not well controlled 9 12
FEV 25-75
Variability Well controlled 25 12
53.8
.075
Not well controlled 12 16
Only FEV1 change showed significant correlation with level of control assessed clinically with kappa coefficient value of 0.350 indicating moderate correlation with significance, whereas FEV1/FVC, FEV25-75%, FEV1 and FEV 25-75% variability was found to be poor predictors of level of control.
DISCUSSION
Our study showed that all of the spirometry parameters improved in about 50% children on follow-up spirometry after regular use of preventers for at least 6 months. Variability also improved in majority of children who showed FEV1 and FEV 25-75% improvement,
This result was similar to those by Anandi et al4 and Singh et al5 where FEV1 showed significant improvement with the use of preventers whereas FEV1/ FVC did not show significant improvement. On comparing the level of control assessed by spirometry with that by ACT score, we found that changes in FEV1 had moderately significant correlation with clinical assessment. Rest of the spirometric parameters showed no significant correlation with clinical level of control.
Study by Chalisse et al6 showed positive correlation between C-ACT and FEV1 at enrolment (r=0.772)(p<.001), 3 months(r=.815)(p<.001) and 6 months (r=.908) (p< .001) at par with our study. Raikar et al7 also showed moderate correlation between FEV1 and ACT scoring ( Pearson linear correlation coefficient 0.5) Similar to our study, studies by Sommanus et al 8 and Anandi et al4 also showed significant correlation between clinical scoring and FEV1 in level of control assessment on follow up. There are many adult studies also comparing ACT score clinically and GINA guidelines in assessing level of control. GINA guidelines has FEV1 as one among the components in determining level of control.
Data regarding the significance of spirometry in childhood asthma are limited. There are not much studies about the individual variability of spirometry parameters on follow up and there is no previous study comparing each spirometry parameter individually with clinical level of control. Available studies are of mixed opinion on whether it correlating or nor correlating
But as ours was a follow up study, we were not able to meet our sample size, as many children were lost follow up. Less sample size is a significant limitation of our study.
Clinical score and spirometry should be used in combination to assess the level of control of asthma. A single tool is not sufficient enough in assessing the level of control.Level of asthma assessment by clinical tools alone may underestimate the degree of control. Spirometry done in such case may reveal the underlying tendency to go for exacerbation and help in further management.
CONCLUSION
Increasing renal cortical echogenicity demonstrated a progressive relationship with worsening biochemical
REFERENCES
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention,2019. Available from www.ginasthma.org
2. Nair SJ, Daigle K L, DeCuir P, Lapin CD, Schramm CM. The influence of pulmonary function testing on the management of asthma in children. J Pediatr. 2005 Dec;147(6):797-801.
3. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al .Standardization of spirometry: EurRespir J. 2005 Aug;26(2):319-38
4. Anandi S, Tullu MS, Lahiri K. Evaluation of symptoms&spirometry in children treated for asthma. Indian J Med Res. 2016 Jul;144(1):124-127.
5. Singh M, Mathew JL,MalhiP,Srinivas BR, Kumar L.Comparison of Improvementin Quality of LifeScore with ObjectiveParameters of PulmonaryFunction in Indian Asthmatic Children Receiving Inhaled Corticosteroid Therapy. Indian Pediatr.2004 Nov;41(11):1143-7.
6. ChaliseSP,Bhatta NK, Singh RR, Prasad MS, Poudel P. Assessment of control of bronchial asthma in children using Childhood Asthma Control Test.Indian J Chest Dis Allied Sci. 2014 Apr-Jun;56(2):75-78.
7. Raikar M A,Pereira S D S.Assessing Asthma Control using Asthma Control Test and Spirometry. International Journal of Contemporary Medical Research 2017;4(8):1689-1693.
8. Sommanus S, Direkwattanachai C, Lawpoolsri S, Sitcharungsi R. Accuracy of childhood asthma control test among Thai childhood asthma patients. Asian Pac J Allergy Immunol. 2018 Sep;36(3):152-158.
9. Andrew H L. Childhood Asthma. KleigmanR.M,Stanton B F,StGeme III J W, Schor N F. In: Nelson Textbook of Pediatrics.20th edition (2) New Delhi: Elsevier, 2016.1095-115.
10. To T, Stanojevic S, Moores G, Gershon A S, Bateman E D, Cruz A A. Global asthma prevalence in adults: findings from the cross-sectional world health survey.BMC Public Health 2012; 12:204.
11. Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009;64(6):476-83.
12. Murray CJ, Vos T, Lozano R. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2197-223.
13. Worldwide variations in the prevalence of asthma symptoms: the international study of Asthma and Allergies in Childhood (ISAAC). Euro Respir J.1998;12(2):315–35.
14. Mathew, A C, Prince, T, Remees R., Saravanapandian, N, Ramalingam S, Srikanth K, et al. Prevalence and Risk Factors of Asthma in School Going Children in South India. Nepal Journal of Epidemiology.2102; 2(1), 171-178.
15. Barreiro TJ, Perillo I: An approach to interpretingspirometry. Am Fam Physician. 2004 Mar 1;69(5):1107-14.
Recommended Articles
Original Article
Comparison of Dexmedetomidine and Esmolol for Controlled Hypotension and Surgical-Field Quality During Functional Endoscopic Sinus Surgery (FESS)
Correlation Between EGFR Mutation Subtypes and Histopathological Features in Predicting Response to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review